ArticleOncoTargets and therapy2021

Clinical and Pathologic Complete Response to Gefitinib in a Patient with SqCLC Harboring EGFR p.E746_S752delinsV Mutation.

Weitao Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.